MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment own, develops, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of April 30, 2021, this segment operated 301 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally-developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
IPO Year: 2020
Exchange: NASDAQ
Website: medirom.co.jp
| Date | Price Target | Rating | Analyst |
|---|
Fastest customizable press release news feed in the world
TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo, President and CEO: Kouji Eguchi, NASDAQ:NASDAQ, hereinafter "MEDIROM"), a company engaged in diversified healthcare businesses, has entered into a Master Service Agreement (the "MSA") with Tools for Humanity ("TFH") and the World Foundation ("WF"), and will support World ID adoption with the installation of Orbs across 3,000 locations nationwide in Japan. Tools for Humanity was co-founded by Sam Altman and Alex Blania and led the initial development of the World Project. The Orb is a device that allows an individual to verify that they are a unique human, and create a secure an
TOKYO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), announces that the cumulative number of Proof of Human authentications using the World ID authentication device ‘Orb' at stores centered on the relaxation salon "Re.Ra.Ku," operated by its subsidiary MEDIROM Wellness Co., surpassed 20,000 as of December 28, 2025. The Company participates in World (a Proof of Human authentication protocol), co-founded by Sam Altman and Alex Blania, and is advancing access to Proof of Human technology via the World Network. This milestone of surpassing 20,000 verifications represents a do
TOKYO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), a diversified healthcare company, collaborating with World Foundation and Tools for Humanity to deploy Proof of Human technologies such as World ID throughout Japan. The World project was co-created by Sam Altman and Alex Blania. In preparation for the full-scale rollout of the World project in Japan, MEDIROM has entered into a Master Service Agreement ("MSA") with Tools for Humanity ("TFH") and World Foundation ("WF"). Under the MSA, the MEDIROM Group will be responsible for the operation of "Proof of Human" verification
TOKYO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM, MEDIROM or the "Company"), a diversified healthcare company, is collaborating with World Foundation and Tools for Humanity to deploy Proof of Human technologies such as World ID throughout Japan. The World project was co-created by Sam Altman and Alex Blania. In preparation for the full-scale rollout of the World project in Japan, MEDIROM has entered into a Master Service Agreement ("MSA") with Tools for Humanity ("TFH") and World Foundation ("WF"). Under the MSA, the MEDIROM Group will be responsible for the operation of "Proof of Human" verificat
TOKYO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("MEDIROM") today announced that its subsidiary, MEDIROM MOTHER Labs Inc. ("MOTHER Labs"), which develops health-tech solutions, has entered into a distributor agreement (the "Agreement") with TD SYNNEX K.K. ("TD SYNNEX"). Through the execution of the Agreement, MOTHER Labs will collaborate with TD SYNNEX to leverage its nationwide sales network and extensive expertise in IT product distribution, with the aim of accelerating the nationwide expansion of the recharge-free smart tracker "MOTHER Bracelet®" and the remote health monitoring system "REMONY®," both developed by MOTHER Labs. ︎Partnership
TOKYO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- MEDIROM MOTHER Labs Co., Ltd. (Headquarters: Minato-ku, Tokyo; President and CEO: Yoshio Uekusa; hereinafter "MEDIROM MOTHER Labs"), a subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM), has completed a private placement of new shares to its President and CEO, Yoshio Uekusa, and Director, Ryo Saito. This transaction is part of the previously announced Series A round, valued at ¥9 billion. ︎Background of ImplementationMEDIROM MOTHER Labs, as the health tech division of the Medirom Group, has been advancing the implementation of specific health guidance utilizing the healthcare app "Lav" and the development and sales of the wearable devi
TOKYO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc., (Headquarters: Minato-ku, Tokyo, President and CEO: Kouji Eguchi, NASDAQ:MRM, hereinafter "the Company") hereby announces the launch of a new treasury strategy utilizing cryptocurrency. As part of this strategy, the Board of Directors has resolved to hold Worldcoin (WLD), a Proof of Human authentication protocol, as a reserve asset, aiming to diversify business activities and mitigate financial risks. As of October 28, 2025, our group holds 6,840 WLD. These held WLD are intended for use through our product, the MOTHER Bracelet, a smart tracker requiring no charging. Specifically, we plan to distribute WLD as an
TOKYO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ((Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM), today announced that as of October 23, 2025, the Company surpassed 10,000 verifications of World ID at its Re.Ra.Ku and other wellness salons throughout Japan. The Company plans to further expand the installation of the Orb, an advanced camera that verifies humanness, to 200 stores. Benefits of Increasing World ID VerificationsMEDIROM has joined the "World," a "proof of human" protocol co-founded by Sam Altman and Alex Blania. As the number of World ID verifications increases, more individuals across society will be able to prove their humanness,
TOKYO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- MEDIROM MOTHER Labs Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Yoshio Uekusa; hereinafter "MOTHER Labs"), a subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM), today announced that it has approved a private placement of new shares to two officers, Yoshio Uekusa, President and CEO, and Ryo Saito, Director, as part of its Series A financing round, at a valuation of JPY9 billion. Funding is scheduled to occur by the end of October. ◼︎Background for ImplementationMOTHER Labs serves as the health tech division within the MEDIROM Group, having previously implemented specific health guidance programs using the healthcare app "La
TOKYO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. ((Headquarters: Minato-ku, Tokyo, CEO: Kouji Eguchi, NASDAQ:MRM), a diversified healthcare company, has joined "World," a "proof of human" protocol co-founded by Sam Altman and Tools for Humanity's CEO, Alex Blania. MEDIROM plans to complete the deployment of the World ID proof of human authentication device Orb across 100 of its Re.Ra.Ku relaxation studios in Japan within this month, and to expand the deployment to 200 locations nationwide further. This expansion marks the largest installation of Orbs in Japan to date, providing greater access to this new social infrastructure that enables individuals to prov
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
6-K - Medirom Healthcare Technologies Inc. (0001819704) (Filer)
Live Leadership Updates
NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan ("MEDIROM", the "Company"), today announced it will participate in a "NASDAQ JAPAN IR EVENT" to be held at Nasdaq MarketSite in Times Square on June 20, 2024. Five companies are currently expected to join this event (including one private company), and we will share information about the attractive nature of the Japanese market with a global audience. PurposeIn December 2020, the Company became the first Japanese company in 21 years to list on Nasdaq. Today, the number of Japanese companies listed on Nasdaq has increased to eight. While more and mor
This live feed shows all institutional transactions in real time.
SC 13G - Medirom Healthcare Technologies Inc. (0001819704) (Subject)
SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)
SC 13D - Medirom Healthcare Technologies Inc. (0001819704) (Subject)
Live finance-specific insights
TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company") is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of Y's, Inc. Prior to the acquisition by MEDIROM Rehab Solutions Inc., Y's, Inc. owned and operated ten cerebral infarction rehabilitation centers in Tokyo and other major cities across Japan. Cerebral infarction rehabilitation is a comprehensive program designed to
TOKYO, June 25, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) ("Medirom" or the "Company"), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), on June 18, 2024. Kouji Eguchi, Chief Executive Officer of the Company, stated, "I am very pleased to announce that during a period of significant investment and development in our healthcare technology systems and products in FY 2023 and FY 2022, as wel
NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the "Company"), today announced its preliminary unaudited financial results for the fiscal year ended December 31, 2021, prepared in accordance with U.S. GAAP. Due to additional time required to complete its year-end reporting process, the Company determined that it was unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, within the prescribed time period without unreasonable effort and expense. The Company filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission o
NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM, "MEDIROM"), a leading holistic health services provider in Japan, today announced MEDIROM's interim financial results for the six month ended June 30, 2021. FY 2021 Interim Financial Highlights Total revenue for the first half of the year increased by 57.0% to JPY2,127 million (US$19.1 million) from JPY1,356 million in a year ago period, due to the recovery from the COVID-19 negative impact in 2020.Cost of revenues increased by 39.4% to JPY1,768 million (US$15.9 million) from JPY1,269 million in a year ago period, as a result of the reopening of the salons and salon acquisitions.SG&A increase
NEW YORK, April 30, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM, "MEDIROM"), a leading holistic health services provider in Japan, announced today that MEDIROM has acquired 100% ownership of SAWAN CO. LTD. ("SAWAN"), a relaxation salon operator of "Ruam Ruam" from BOX GROUP Co., Ltd., a Japanese holding company specializing in beauty and spa products and services. Ruam Ruam is a luxury relaxation salon brand, which is characterized with Oriental relaxation techniques to fit the needs and preferences of the Japanese consumer. SAWAN directly operates eight (8) salons across the Tokyo metropolitan area. In addition, SAWAN entered into an agreement with Nine R